Introduction: emerging therapies derived from the molecular pathogenesis of secondary hyperparathyroidism in ESRD patients.

L Darryl Quarles

Journal: Advances in renal replacement therapy 2002;9(3):153-8

PMID: 12203196

Abstract

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.